Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

interviews

UK flag

UK budget 2012: Industry welcomes £600m for science research

Chancellor also makes new cut in corporation tax and plans next steps to support life sciences

- PMLiVE

Novartis calls for improvements to UK clinical trial system

Says cost of running studies in the country undermines its attractiveness

Novartis building

Novartis to issue stark warning to UK at crisis meeting

Says UK needs to address decline in pharma R&D

Eisai: Bucking the trend with R&D growth

PME’s emerging companies series continues with a firm that’s committed to research as it expands its commercial position

Under threat: The pharma industry in Spain

The Eurozone crisis threatens healthcare and pharma opportunities

UK flag

UK could allow patented drugs to be used in clinical trials

Government proposes update to Patents Act to restrict when companies can sue for infringement

Eisai’s epilepsy drug Fycompa gets green light in US

Japanese firm predicts global sales of more than $1bn at peak

- PMLiVE

Vivus fails to get European backing for obesity treatment Qsiva

EMA raises concerns about drug’s cardiovascular safety

- PMLiVE

VIDEO: Eisai manufacturing plans shows UK is recovering from ‘shock’ of Pfizer/AZ cutbacks

David Willetts says life sciences industry has future in UK at opening of Fycompa manufacturing site

Eisai launches epilepsy drug Fycompa in UK

CEO of Eisai EMEA Gary Hendler says UK “last free pricing market in Europe”

UK flag

Life sciences industry wants more from new UK business strategy

BIA and ABPI welcome measures but tell government more can be done

FDA sued for approving high dose of Eisai’s Alzheimer’s drug Aricept

Consumer rights group Public Citizen claims the high-strength dose is unsafe

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links